Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism

Dorrah Deeb, Xiaohua Gao, Hao Jiang, Branislava Janic, Ali Syed Arbab, Yon Rojanasakul, Scott A. Dulchavsky, Subhash C. Gautam

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

CDDO-Me, a synthetic triterpenoid derived from oleanolic acid, is a promising anticancer agent that has shown strong activity against a wide variety of cancer types in vitro and in vivo. We have previously shown that CDDO-Me induces apoptosis in prostate cancer cells irrespective of their hormonal status. To further understand the proapoptotic mechanism of CDDO-Me, we investigated the role of reactive oxygen species (ROS) in mediating the apoptosis inducing activity of CDDO-Me in LNCaP and PC-3 prostate cancer cell lines. Here, we show that CDDO-Me induces ROS generation from both nonmitochondrial and mitochondrial sources, which is associated with the induction of apoptosis as characterized by increased annexin V-binding, cleavage of PARP-1 and procaspases-3, -8, -9, loss of mitochondrial membrane potential and release of cytochrome c. In addition, CDDO-Me inhibited cell survival Akt, NF-κB and mTOR signaling proteins. The inhibition of ROS generation by N-acetylcysteine (NAC) or by overexpression of antioxidant enzymes glutathione peroxidase (GPx) and superoxide dismutase-1 (SOD-1) prevented CDDO-Me-induced apoptosis. Pretreatment with NAC blocked annexin V-binding, cleavage of PARP-1 and procaspases-3, -8, -9, loss of mitochondrial membrane potential and release of cytochrome c by CDDO-Me. NAC also prevented the inhibition of constitutively active Akt, NF-κB and mTOR by CDDO-Me. Together, these data indicate that ROS plays an essential role in the induction of apoptosis by CDDO-Me in prostate cancer cells.

Original languageEnglish (US)
Pages (from-to)350-360
Number of pages11
JournalBiochemical Pharmacology
Volume79
Issue number3
DOIs
StatePublished - Feb 1 2010
Externally publishedYes

Fingerprint

Reactive Oxygen Species
Prostatic Neoplasms
Cells
Apoptosis
Growth
Acetylcysteine
Caspase 8
Mitochondrial Membrane Potential
Annexin A5
Cytochromes c
Caspase 3
TOR Serine-Threonine Kinases
Oleanolic Acid
Membranes
methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate
oleanane
Glutathione Peroxidase
Antineoplastic Agents
Superoxide Dismutase
Cell Survival

Keywords

  • Apoptosis
  • CCDO-Me
  • Cell survival signaling
  • Mitochondrial depolarization
  • Prostate cancer
  • ROS

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology

Cite this

Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism. / Deeb, Dorrah; Gao, Xiaohua; Jiang, Hao; Janic, Branislava; Arbab, Ali Syed; Rojanasakul, Yon; Dulchavsky, Scott A.; Gautam, Subhash C.

In: Biochemical Pharmacology, Vol. 79, No. 3, 01.02.2010, p. 350-360.

Research output: Contribution to journalArticle

Deeb, Dorrah ; Gao, Xiaohua ; Jiang, Hao ; Janic, Branislava ; Arbab, Ali Syed ; Rojanasakul, Yon ; Dulchavsky, Scott A. ; Gautam, Subhash C. / Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism. In: Biochemical Pharmacology. 2010 ; Vol. 79, No. 3. pp. 350-360.
@article{7b8f047916f9463b8b3be8b1d426ab2f,
title = "Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism",
abstract = "CDDO-Me, a synthetic triterpenoid derived from oleanolic acid, is a promising anticancer agent that has shown strong activity against a wide variety of cancer types in vitro and in vivo. We have previously shown that CDDO-Me induces apoptosis in prostate cancer cells irrespective of their hormonal status. To further understand the proapoptotic mechanism of CDDO-Me, we investigated the role of reactive oxygen species (ROS) in mediating the apoptosis inducing activity of CDDO-Me in LNCaP and PC-3 prostate cancer cell lines. Here, we show that CDDO-Me induces ROS generation from both nonmitochondrial and mitochondrial sources, which is associated with the induction of apoptosis as characterized by increased annexin V-binding, cleavage of PARP-1 and procaspases-3, -8, -9, loss of mitochondrial membrane potential and release of cytochrome c. In addition, CDDO-Me inhibited cell survival Akt, NF-κB and mTOR signaling proteins. The inhibition of ROS generation by N-acetylcysteine (NAC) or by overexpression of antioxidant enzymes glutathione peroxidase (GPx) and superoxide dismutase-1 (SOD-1) prevented CDDO-Me-induced apoptosis. Pretreatment with NAC blocked annexin V-binding, cleavage of PARP-1 and procaspases-3, -8, -9, loss of mitochondrial membrane potential and release of cytochrome c by CDDO-Me. NAC also prevented the inhibition of constitutively active Akt, NF-κB and mTOR by CDDO-Me. Together, these data indicate that ROS plays an essential role in the induction of apoptosis by CDDO-Me in prostate cancer cells.",
keywords = "Apoptosis, CCDO-Me, Cell survival signaling, Mitochondrial depolarization, Prostate cancer, ROS",
author = "Dorrah Deeb and Xiaohua Gao and Hao Jiang and Branislava Janic and Arbab, {Ali Syed} and Yon Rojanasakul and Dulchavsky, {Scott A.} and Gautam, {Subhash C.}",
year = "2010",
month = "2",
day = "1",
doi = "10.1016/j.bcp.2009.09.006",
language = "English (US)",
volume = "79",
pages = "350--360",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism

AU - Deeb, Dorrah

AU - Gao, Xiaohua

AU - Jiang, Hao

AU - Janic, Branislava

AU - Arbab, Ali Syed

AU - Rojanasakul, Yon

AU - Dulchavsky, Scott A.

AU - Gautam, Subhash C.

PY - 2010/2/1

Y1 - 2010/2/1

N2 - CDDO-Me, a synthetic triterpenoid derived from oleanolic acid, is a promising anticancer agent that has shown strong activity against a wide variety of cancer types in vitro and in vivo. We have previously shown that CDDO-Me induces apoptosis in prostate cancer cells irrespective of their hormonal status. To further understand the proapoptotic mechanism of CDDO-Me, we investigated the role of reactive oxygen species (ROS) in mediating the apoptosis inducing activity of CDDO-Me in LNCaP and PC-3 prostate cancer cell lines. Here, we show that CDDO-Me induces ROS generation from both nonmitochondrial and mitochondrial sources, which is associated with the induction of apoptosis as characterized by increased annexin V-binding, cleavage of PARP-1 and procaspases-3, -8, -9, loss of mitochondrial membrane potential and release of cytochrome c. In addition, CDDO-Me inhibited cell survival Akt, NF-κB and mTOR signaling proteins. The inhibition of ROS generation by N-acetylcysteine (NAC) or by overexpression of antioxidant enzymes glutathione peroxidase (GPx) and superoxide dismutase-1 (SOD-1) prevented CDDO-Me-induced apoptosis. Pretreatment with NAC blocked annexin V-binding, cleavage of PARP-1 and procaspases-3, -8, -9, loss of mitochondrial membrane potential and release of cytochrome c by CDDO-Me. NAC also prevented the inhibition of constitutively active Akt, NF-κB and mTOR by CDDO-Me. Together, these data indicate that ROS plays an essential role in the induction of apoptosis by CDDO-Me in prostate cancer cells.

AB - CDDO-Me, a synthetic triterpenoid derived from oleanolic acid, is a promising anticancer agent that has shown strong activity against a wide variety of cancer types in vitro and in vivo. We have previously shown that CDDO-Me induces apoptosis in prostate cancer cells irrespective of their hormonal status. To further understand the proapoptotic mechanism of CDDO-Me, we investigated the role of reactive oxygen species (ROS) in mediating the apoptosis inducing activity of CDDO-Me in LNCaP and PC-3 prostate cancer cell lines. Here, we show that CDDO-Me induces ROS generation from both nonmitochondrial and mitochondrial sources, which is associated with the induction of apoptosis as characterized by increased annexin V-binding, cleavage of PARP-1 and procaspases-3, -8, -9, loss of mitochondrial membrane potential and release of cytochrome c. In addition, CDDO-Me inhibited cell survival Akt, NF-κB and mTOR signaling proteins. The inhibition of ROS generation by N-acetylcysteine (NAC) or by overexpression of antioxidant enzymes glutathione peroxidase (GPx) and superoxide dismutase-1 (SOD-1) prevented CDDO-Me-induced apoptosis. Pretreatment with NAC blocked annexin V-binding, cleavage of PARP-1 and procaspases-3, -8, -9, loss of mitochondrial membrane potential and release of cytochrome c by CDDO-Me. NAC also prevented the inhibition of constitutively active Akt, NF-κB and mTOR by CDDO-Me. Together, these data indicate that ROS plays an essential role in the induction of apoptosis by CDDO-Me in prostate cancer cells.

KW - Apoptosis

KW - CCDO-Me

KW - Cell survival signaling

KW - Mitochondrial depolarization

KW - Prostate cancer

KW - ROS

UR - http://www.scopus.com/inward/record.url?scp=70449651686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449651686&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2009.09.006

DO - 10.1016/j.bcp.2009.09.006

M3 - Article

C2 - 19782051

AN - SCOPUS:70449651686

VL - 79

SP - 350

EP - 360

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 3

ER -